Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-AMLODIPINE-ATORVASTATIN | 80MG 10MG | TABLET | Resolved | 2024-08-22 | 2024-09-06 | 235705 |
| APO-AMOXI | 500MG | CAPSULE | Resolved | 2019-10-23 | 2019-11-05 | 97034 |
| APO-AMOXI | 250MG | POWDER FOR SUSPENSION | Resolved | 2020-01-08 | 2020-07-30 | 102528 |
| APO-AMOXI | 125MG | POWDER FOR SUSPENSION | Resolved | 2020-03-04 | 2020-06-24 | 107690 |
| APO-AMOXI | 125MG | POWDER FOR SUSPENSION | Resolved | 2020-07-08 | 2020-07-24 | 119693 |
| APO-AMOXI | 125MG | POWDER FOR SUSPENSION | Resolved | 2020-11-04 | 2021-01-29 | 127751 |
| APO-AMOXI | 250MG | POWDER FOR SUSPENSION | Resolved | 2022-06-17 | 2024-02-14 | 162918 |
| APO-AMOXI | 125MG | POWDER FOR SUSPENSION | Resolved | 2022-08-12 | 2024-02-14 | 166621 |
| APO-AMOXI | 500MG | CAPSULE | Resolved | 2022-11-27 | 2023-01-06 | 175904 |
| APO-AMOXI | 250MG | CAPSULE | Resolved | 2022-12-05 | 2023-04-14 | 177129 |
| APO-AMOXI | 500MG | CAPSULE | Resolved | 2024-12-05 | 2025-01-03 | 244926 |
| APO-AMOXI | 250MG | POWDER FOR SUSPENSION | Resolved | 2025-05-08 | 2025-06-20 | 256914 |
| APO-AMOXI | 125MG | POWDER FOR SUSPENSION | Resolved | 2025-08-21 | 2025-09-12 | 265829 |
| APO-AMOXI CLAV | 400MG 57MG | POWDER FOR SUSPENSION | Resolved | 2017-03-10 | 2019-05-18 | 41 |
| APO-AMOXI CLAV | 875MG 125MG | TABLET | Resolved | 2019-06-19 | 2019-09-23 | 87057 |
| APO-AMOXI CLAV | 250MG 125MG | TABLET | Resolved | 2020-01-15 | 2020-02-19 | 103357 |
| APO-AMOXI CLAV | 125MG 250MG | TABLET | Resolved | 2022-02-11 | 2022-02-18 | 154749 |
| APO-AMOXI CLAV | 125MG 875MG | TABLET | Resolved | 2022-10-28 | 2022-11-11 | 172960 |
| APO-AMOXI CLAV | 125MG 250MG | TABLET | Resolved | 2022-12-05 | 2023-01-06 | 177132 |
| APO-AMOXI CLAV | 125MG 875MG | TABLET | Resolved | 2023-02-16 | 2023-03-16 | 185039 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-HYDROMORPHONE CR | 12MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110962 |
| APO-HYDROMORPHONE CR | 18MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110965 |
| APO-HYDROMORPHONE CR | 24MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110968 |
| APO-HYDROMORPHONE CR | 30MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110971 |
| APO-HYDROMORPHONE CR | 4.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110974 |
| APO-HYDROMORPHONE CR | 9MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-04-04 | 2020-04-04 | 110977 |
| APO-HYDROXYQUINE | 200MG | TABLET | Discontinued | 2018-09-07 | 2018-10-05 | 60524 |
| APO-IMIQUIMOD | Discontinued | 2019-11-26 | 2019-11-26 | 99672 | ||
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60536 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60539 |
| APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
| APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
| APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
| APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LAMIVUDINE | 150MG | TABLET | Discontinued | 2018-09-07 | 2019-07-13 | 60557 |